patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the … biotherapeutics tocilizumab, siltuximab and sarilumab. … support national patent offices and interested parties in developing countries with information that can serve as guidance for …

prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing … countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent … applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …

Rights (TRIPS Agreement) and Public Health adopted by the World Trade Organization, we realize that its impact is beyond … issues of public health stricto sensu. The Doha Declaration has inspired discussions at the Council for TRIPS regarding … effects on public health, especially for the vulnerable communities in the Global-South. The main argument of the proponents …

important in the context of the COVID-19 pandemic, which has once again highlighted the same public health issues that the Doha …-Related Aspects of Intellectual Property Rights (TRIPS Agreement), however, included a number of public health flexibilities in order … to provide latitude to the Member States to tailor their national patent laws to fit their individual needs. In 2001, the …